Overview

[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease

Status:
Completed

Trial end date:
2019-12-31

Target enrollment:

Participant gender:

Summary

This is a cross-sectional and longitudinal study to evaluate the clinical utility of [18F]THK-5351 positron emission computed tomography in cognitively healthy volunteers, mild cognitive impairment (MCI), Alzheimer's disease (AD) and other neurodegenerative patients.

Phase:

Phase 2

Details

Lead Sponsor:

Jae Seung Kim

Collaborators:

Korea Health Industry Development Institute
Samsung Medical Center